Navigation Links
IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter
Date:5/5/2011

day an archived version of the webcast will be available on the Company's website at www.iridex.com.

About IRIDEX IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.

Safe Harbor StatementThis announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the Company's strategic plans, growth initiatives, new products and projected 2011 financial results.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended January 1, 2011 which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

TABLES FOLLOWIRIDEX CorporationCondensed Consolidated Statements of Operations(Unaudited, in thousands
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery
2. IRIDEX Announces First Quarter 2011 Conference Call and Release Date
3. IRIDEX to Present at the Roth OC Growth Stock Conference in Dana Point, CA
4. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
5. IRIDEX to Present at the OneMedForum San Francisco 2011 Conference
6. IRIDEX Reports Improved Third Quarter 2010 Financial Results
7. IRIDEX Announces Third Quarter 2010 Conference Call and Release Date
8. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
9. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
10. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
11. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  ResMed (NYSE: ... a definitive agreement to acquire Curative Medical, ... and sleep-disordered breathing medical devices and accessories. ... in China, combined with ResMed,s global leadership in sleep and respiratory ... China suffering from sleep-disordered ...
(Date:7/30/2015)... 30, 2015  EP Global Communications, Inc. (Public OTC: ... contacted the Company about discussing EPGL,s electronic contact ... Monday, August 3, 2015.  Novartis CEO Joe ... the coming electronic contact lens market could be ... next several years.  Novartis partnered with Google in ...
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... , HAYWARD, Calif., Nov. 17 ... today announced that its readerless CD4 point-of-care (POC) technology ... as the best-performing POC test method for measuring CD4 T-cell ... only remaining POC product being supported by the CD4 Initiative. ...
... , BEDFORD, Mass., Nov. 16 Hologic, ... a leading developer, manufacturer and supplier of premium diagnostics, ... the healthcare needs of women, is participating in the ... November 15-19, 2009 in Orlando, Florida, and will feature ...
Cached Medicine Technology:Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries 2Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries 3Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009 2Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009 3Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009 4
(Date:7/30/2015)... ... July 30, 2015 , ... The Beryl Institute ... Program. In partnership with Patient Experience Institute, these offerings reinforce the commitment to ... front lines and throughout the experience movement, and provide information and research to ...
(Date:7/30/2015)... Melbourne, FL (PRWEB) , ... July 30, 2015 , ... ... Central Florida’s (UCF) College of Medicine as Assistant Professor of Plastic Surgery. This ... years, Dr. Clevens has worked closely with the university, developing a strong presence and ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. The bill was introduced ... (R-NY), Peter King (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance ...
(Date:7/30/2015)... ... July 30, 2015 , ... Using the latest online digital ... people more effective ways to prevent and manage major depression. , “Suicide is 100% ... so people fall through the cracks and die needlessly everyday,” says Walker. “I’m out ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Partners All-Star at the annual All-Stars Summit. Google Partners is the platform for ... may receive the full support and tools necessary to run successful search marketing ...
Breaking Medicine News(10 mins):Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2
... (BIDMC) has been awarded a grant from the National ... the National Institutes of Health, to lead a Consortium ... grant totals $36 million. BIDMC Chief of Vaccine ... Medicine at Harvard Medical School, will co-lead the new ...
... Bristol-Myers Squibb Company announced results from a long-term, ... (ARV)-experienced patients (336 female and 958 male) from ... at the Sixth International AIDS Society Conference on ... In a gender-specific sub-analysis, boosted REYATAZ (atazanavir sulphate) ...
... (HealthDay News) -- Personality traits may play key roles in ... from the U.S. National Institute on Aging found that people ... to be overweight. And those who are highly neurotic and ... many ups and downs. "Individuals with this constellation of ...
... , TUESDAY, July 19 (HealthDay News) -- People who ... able to decide what they like or don,t like more ... the study, published in the Journal of Consumer Research ... either likable subjects (puppies) or unpleasant things (diseased feet) or ...
... falling into poverty is an increasingly common experience among ... jointly by the Heller School,s Institute on Assets and ... organization Demos. And, researchers say, the situation could ... The report, "From Bad to Worse: Senior Economic ...
... large waist size is unhealthy for anyone, but for kidney disease ... of dying, a new study reports. The study doesn,t ... it suggests there may be a link. In their ... aged 45 and older who had kidney disease. The patients were ...
Cached Medicine News:Health News:In the real life setting, boosted REYATAZ proves as effective in women living with HIV as men 2Health News:Does Your Personality Dictate Whether You'll Be Overweight? 2Health News:Happy Shoppers More Decisive When Purchasing 2Health News:New report shows seniors' economic security falling 2Health News:As Waistline Expands, So Does Death Risk for Kidney Patients 2
... the use of plates and screws in the treatment ... pins in the forearm or ankle is not a ... lock the pins or hold them in place. A ... out of the implant. The SST® (Stainless Steel Taper) ...
... 36 cc and 73 grams, the Epic ... care and simplified follow-up. The Epic HF ... 30 joule (delivered energy) biventricular ICD. Small ... HF ICD features advanced resynchronization parameters along ...
... has greatly enhanced the stabilization ... Biomet Low Profile Tibial Nail ... treatment of unstable fractures, tibial ... pathologic or impending fractures but ...
The Charlotte Shoulder™ System address arthroscopic, mini-open and open procedures with time saving instrumentation....
Medicine Products: